Bayesian Capital Management’s Arrowhead Research ARWR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-13,000
Closed -$166K 545
2025
Q1
$166K Buy
+13,000
New +$236K 0.03% 511
2024
Q2
Sell
-25,303
Closed -$724K 721
2024
Q1
$724K Buy
+25,303
New +$809K 0.07% 356
2023
Q2
Sell
-32,682
Closed -$830K 786
2023
Q1
$830K Buy
+32,682
New +$1.03M 0.1% 270
2020
Q4
Sell
-6,966
Closed -$300K 453
2020
Q3
$300K Buy
+6,966
New +$301K 0.07% 344
2020
Q2
Sell
-11,334
Closed -$326K 525
2020
Q1
$326K Buy
11,334
+6,500
+134% +$262K 0.07% 421
2019
Q4
$307K Buy
+4,834
New +$240K 0.05% 421

Other funds holding ARWR

Bayesian Capital Management's ARWR Position: Q2 2025 in Review

Bayesian Capital Management sold out of Arrowhead Research (ARWR) in Q2 2025, closing a stake of 13,000 shares — an estimated $166K sold.

Bayesian Capital Management first reported a position in ARWR in Q4 2019 and held it in 6 quarters. The position peaked at $830K in Q1 2023. 282 funds tracked by Wall St. Rank hold ARWR as of Q2 2025.

  • Bayesian Capital Management reported no remaining Arrowhead Research position as of Q2 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 13,000 Arrowhead Research shares in Q2 2025, an estimated $166K.
  • Bayesian Capital Management first reported a position in Arrowhead Research in Q4 2019 and held it in 6 quarters.
  • Bayesian Capital Management's Arrowhead Research position peaked at $830K in Q1 2023.
  • 282 funds tracked by Wall St. Rank held Arrowhead Research as of Q2 2025.

Based on Bayesian Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.